Ovid Therapeutics (OVID) Capital Expenditures (QoQ) (2016 - 2024)
Ovid Therapeutics (OVID) Capital Expenditures (QoQ) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ovid Therapeutics |
311.83 Mn |
156.31 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-141.27% |
| Sep 30, 2024 |
85.29% |
| Jun 30, 2024 |
78.95% |
| Mar 31, 2024 |
46.15% |
| Dec 31, 2023 |
115.66% |
| Sep 30, 2023 |
-186.46% |
| Jun 30, 2023 |
585.71% |
| Mar 31, 2023 |
-98.56% |
| Dec 31, 2022 |
216.60% |
| Sep 30, 2022 |
-179.05% |
| Jun 30, 2022 |
3,391.93% |
| Sep 30, 2021 |
-153.10% |
| Dec 31, 2020 |
-76.60% |
| Sep 30, 2020 |
214.31% |
| Jun 30, 2020 |
-196.23% |
| Mar 31, 2020 |
4.55% |
| Dec 31, 2019 |
48,717.30% |
| Sep 30, 2019 |
-70.28% |
| Jun 30, 2019 |
-73.23% |
| Mar 31, 2019 |
123.22% |
